Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Looking Beyond the Provision of Injecting Equipment to People Who Use Anabolic Androgenic Steroids: Harm Reduction and Behavior Change Goals for UK Policy
Geoff Bates, Jim McVeigh, Conan Leavey
Contemporary Drug Problems (2021) Vol. 48, Iss. 2, pp. 135-150
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

The world's first anabolic‐androgenic steroid testing trial: A two‐phase pilot combining chemical analysis, results dissemination and community feedback
Timothy Piatkowski, Ross Coomber, Cameron Francis, et al.
Addiction (2025)
Open Access | Times Cited: 3
“They sent it away for testing and it was all bunk”: Exploring perspectives on drug checking among steroid consumers in Queensland, Australia
Timothy Piatkowski, Cheneal Puljević, Cameron Francis, et al.
International Journal of Drug Policy (2023) Vol. 119, pp. 104139-104139
Open Access | Times Cited: 32
“Emerging anabolic androgenic steroid markets; the prominence of social media”
Luke Cox, Nick Gibbs, Luke A. Turnock
Drugs Education Prevention and Policy (2023) Vol. 31, Iss. 2, pp. 257-270
Closed Access | Times Cited: 29
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
Exploring the role of community pharmacies as a harm reduction environment for anabolic–androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists
Timothy Piatkowski, Sarah Benn, Lkhagvadulam Ayurzana, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care
Timothy Piatkowski, Luke Cox, Nick Gibbs, et al.
Drugs Education Prevention and Policy (2024), pp. 1-9
Closed Access | Times Cited: 13
Navigating Risks and Reducing Harm: A Gendered Analysis of Anabolic–Androgenic Steroid Users Within the Risk Environment Framework
Timothy Piatkowski, Matthew Dunn
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 111-128
Open Access | Times Cited: 12
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
“You Could Try This Compound, but it Might Send You nuts”: How Steroid Suppliers Perceive the Underground Market and Their ‘Hybrid’ Role within It
Timothy Piatkowski, Steve Vigorous, Luke Cox, et al.
Deviant Behavior (2024), pp. 1-12
Open Access | Times Cited: 5
Consuming ‘God Juice’: Using ‘ethnopharmacological‐connoisseurship’ to situate trenbolone use and knowledge among image and performance enhancing drug communities
Timothy Piatkowski, Nick Gibbs, David L. Neumann, et al.
Drug and Alcohol Review (2024)
Open Access | Times Cited: 4
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle A. King, et al.
Substance Abuse Treatment Prevention and Policy (2025) Vol. 20, Iss. 1
Open Access
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis
Razieh Chegeni, Guy Notelaers, Ståle Pallesen, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 22
Stigma and the Use of Anabolic Androgenic Steroids by Men in the United Kingdom
Jim McVeigh, Geoff Bates
Springer eBooks (2022), pp. 121-146
Closed Access | Times Cited: 13
Harm reduction strategies for androgen users: providing appropriate support and improving engagement with healthcare
Geoff Bates, Scott T.C. Shepherd, Jim McVeigh
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 630-635
Open Access | Times Cited: 16
Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Two sides of the same coin: A qualitative exploration of experiential and perceptual factors which influence the clinical interaction between physicians and Anabolic-Androgenic Steroid using patients in the UK
Neha Prasad Ainsworth, Sam N. Thrower, Andrea Petróczi
Emerging Trends in Drugs Addictions and Health (2022) Vol. 2, pp. 100033-100033
Open Access | Times Cited: 9
Enhancing autonomy through the ‘Enhanced Games’
Luke Cox, Timothy Piatkowski
Performance Enhancement & Health (2024) Vol. 12, Iss. 4, pp. 100296-100296
Open Access | Times Cited: 1
Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm
Geoff Bates, Robert Ralphs, Vincent Walker Bond, et al.
International Journal of Drug Policy (2022) Vol. 107, pp. 103801-103801
Open Access | Times Cited: 6
Applying insights from implementation and intervention science to improve the evidence base on image and performance-enhancing drugs (IPEDs) interventions
Geoff Bates, Anders Vinther
Performance Enhancement & Health (2021) Vol. 9, Iss. 2, pp. 100193-100193
Open Access | Times Cited: 7
Androgen abuse among gay and bisexual men
Scott Griffiths, Dejan Jotanovic, Emma Austen
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 589-594
Closed Access | Times Cited: 6
Managing risks and harms associated with the use of anabolic steroids: a qualitative study
Julio Mario Xerfan do Amaral, Andreas Kimergård, Paolo Deluca
Research Square (Research Square) (2024)
Open Access
Development and validation of dependence and craving measures specific to athletes who use anabolic-androgenic steroids
Barnaby N. Zoob Carter, Ian D. Boardley
Frontiers in Psychology (2024) Vol. 15
Open Access
Aggression and criminality in androgen abusers
Razieh Chegeni, Ståle Pallesen, Dominic Sagoe
Current Opinion in Endocrinology Diabetes and Obesity (2021) Vol. 28, Iss. 6, pp. 615-624
Closed Access | Times Cited: 2
“Pharmacies are less confronting than a medical practitioner”: A qualitative exploration of community pharmacy as an environment for reducing harms related to anabolic-androgenic steroid use
Timothy Piatkowski, Sarah Benn, Michelle A. King, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top